|View printer-friendly version|
|September 08, 2007 1:56 p.m.|
|Teva Provides Update On Generic Famvir® Litigation|
Jerusalem, Israel, September 8, 2007 - Teva Pharmaceutical Industries Ltd. (Nasdaq:TEVA) announced today that further to its press release dated September 7, 2007, it has received notice that the United States Court of Appeals for the Federal Circuit has issued an order temporarily enjoining the Company from further sales of generic Famciclovir Tablets, AB-rated to Novartis' Famvir® Tablets. The injunction will remain in place pending consideration of Novartis' emergency motion for a stay pending appeal. Teva's response to Novartis' emergency motion is due Tuesday, September 11, 2007.